Counselling Service for Low-income EM in Hong Kong
The Effectiveness of Counselling on Mood Symptoms of Low-income Ethnic Minorities in Hong Kong: a Wait-list Randomised Controlled Trial
This study will recruit 120 ethnic minorities in Hong Kong from the Zubin Foundation (TZF) at the Ethnic Minority Well-being Centre (EMWBC), which is a service provider of EM mental health support in Hong Kong. This service provides counselling service and referrals to HA via the Integrated Community Centre for Mental Wellness (ICCMW) to psychiatrists. The service covers the South Asians population of approximately eighty-four thousands people in Hong Kong. Participants will be recruited by the Zubin Foundation through outreach activities screening and counselling will be conducted in partnering schools and NGOs (e.g., Yan Oi Tong in Tuen Mun and Yew Chung College of Early Childhood Education in Aberdeen).
The study aims to evaluate the effectiveness of counselling service for improving mood symptoms in EM, also to assess the effectiveness of counselling service in improving psychological functioning (i.e. resilience and rumination, self-compassion, self-efficacy and life satisfaction), social functioning and quality of life and to assess whether the counselling service is cost-effective and offers good value for money.
The study is a wait-list RCT. Participants will be randomly assigned into either the intervention group (n = 60) or the wait-list control group (n = 60) in a 1:1 ratio. Each participant in the intervention group will be paired up with a participant from the control group, the number of sessions and duration of waiting period varies depending on the severity of mood symptoms. Participants with mild to moderate mood symptoms will receive a maximum of 6 counselling sessions and will be assessed at baseline (T0, W1), at post
-treatment for counselling group (T1, W8), and after 2 booster sessions. Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention. Participants with severe mood symptoms will receive a maximum of 10 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W12), and after 2 booster sessions. Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
This evaluation study will provide data to inform the government in mental health policy review and development.
Visão geral do estudo
Tipo de estudo
Inscrição (Antecipado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Yi Nam Suen, PhD
- Número de telefone: 39179579
- E-mail: suenyn@hku.hk
Locais de estudo
-
-
-
Hong Kong, Hong Kong
- Recrutamento
- University of Hong Kong
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- South Asian ethnic minorities (except domestic helper) in Hong Kong;
- 15 - 64 years
- reach at least the mild level of the Depression Anxiety Stress Scales - 21 Items in at least one of the following scores: the Depression Score (DASS-D), Anxiety Score (DASS-A) or Stress Score (DASS-S), or low Quality of Life score
- have sufficient proficiency in English, Hindi or Urdu to understand verbal instructions and give informed consent.
Exclusion Criteria:
- from high-income family (cut off ranges from HK$15K for single person family to HK$45K of 6 or more people family)
- mental conditions that require other treatment priorities (e.g., suicidal risk, substance abuse, current or past episodes of psychotic disorder, personality disorders)
- medical conditions that severely limit participation, comprehension, or adherence to treatment (e.g., epilepsy, dementia, terminal medical illness) and,
- current usage of antidepressant or mood stabilizers.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Counselling group
Counselling sessions will be conducted at the designated centers operated by the Zubin foundation.
According to the level of the DASS score, 6 to 10 sessions (based on the algorithm) of counselling service will be provided to the participants by three registered counsellors.
A lead counsellor will oversee all cases and services.
The counselling program consists of 6-10 60-minute sessions, and the sessions can be flexibly delivered over 1 to 2 weeks, ranging from one 60-minute session biweekly or weekly.
|
Participants with mild to moderate mood symptoms will receive a maximum of 6 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W8), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
Participants with severe mood symptoms will receive a maximum of 10 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W12), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
|
|
Outro: Waiting group
For participants in the waiting list control group, they will receive monitoring service over phone calls during the 8-12 weeks wait period.
Counselling service will be offered after the post-treatment assessment.
|
Participants with mild to moderate mood symptoms will receive a maximum of 6 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W8), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
Participants with severe mood symptoms will receive a maximum of 10 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W12), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
The change of the level of depressive symptoms
Prazo: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Depression sub-scale of Depression, Anxiety and Stress Scale 21-item version.
The subscale has 7 items, each rated from 0 to 3, the total score will be doubled for interpretation of its severity.
The higher score indicates the more severe depressive symptoms.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
|
The change of the level of anxiety symptoms
Prazo: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Anxiety sub-scale of Depression, Anxiety and Stress Scale 21-item version.
The subscale has 7 items, each rated from 0 to 3, the total score will be doubled for interpretation of its severity.
The higher score indicates the more severe depressive symptoms.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
|
The change of the level of stress symptoms
Prazo: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Stress sub-scale of Depression, Anxiety and Stress Scale 21-item version.
The subscale has 7 items, each rated from 0 to 3, the total score will be doubled for interpretation of its severity.
The higher score indicates the more severe depressive symptoms.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
The change of subjective quality of life
Prazo: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Mental Component Summary (MCS) of Short Form 12 version 2. Min: 0, max:100.
The higher score indicates better mental health related subjective quality of life.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Eric Yu Hai Chen, MD, The University of Hong Kong
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- EM RCT
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .